Literature DB >> 28185988

Effects of nonsteroidal anti-inflammatory drugs on the renal excretion of indoxyl sulfate, a nephro-cardiovascular toxin, in rats.

Chung-Ping Yu1, Douglas H Sweet2, Yu-Hsuan Peng3, Yow-Wen Hsieh4, Pei-Dawn Lee Chao3, Yu-Chi Hou4, Shiuan-Pey Lin5.   

Abstract

Chronic kidney disease (CKD) is a health problem worldwide. Indoxyl sulfate (IS) is a nephro-cardiovascular toxin accumulated in CKD patients and cannot be removed through hemodialysis. The renal excretion of IS was mediated by organic anion transporters (OATs) OAT 1 and OAT 3. Because a number of nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to inhibit OATs, we hypothesize that NSAIDs might inhibit the renal excretion of IS. Rats were intravenously injected IS with and without diclofenac, ketoprofen or salicylic acid, individually. Blood samples were collected at predetermined time points and the concentrations of IS were determined by HPLC method. The results showed that diclofenac and ketoprofen at 10.0mg/kg significantly decreased the systemic clearance of IS by 71% and 82%, and increased the MRT of IS by 106% and 105%, respectively, whereas salicylic acid did not exhibit significant effects. Cell studies indicated that diclofenac and ketoprofen inhibited the uptake of IS mediated by OAT 1 and OAT 3. In conclusion, diclofenac and ketoprofen inhibited the excretion of IS through inhibition on OAT 1 and OAT 3.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Indoxyl sulfate; NSAIDs; Organic anion transporters; Uremic toxin

Mesh:

Substances:

Year:  2017        PMID: 28185988     DOI: 10.1016/j.ejps.2017.02.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  10 in total

1.  Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters.

Authors:  Xiaokui Huo; Qiang Meng; Changyuan Wang; Jingjing Wu; Chong Wang; Yanna Zhu; Xiaodong Ma; Huijun Sun; Kexin Liu
Journal:  Br J Pharmacol       Date:  2020-03-05       Impact factor: 8.739

Review 2.  Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.

Authors:  Alexander J Prokopienko; Thomas D Nolin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-09-20       Impact factor: 5.045

Review 3.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

4.  Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.

Authors:  Wei Wu; Kevin T Bush; Sanjay K Nigam
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

5.  Effects of diclofenac on the pharmacokinetics of celastrol in rats and its transport.

Authors:  Zengfu Wang; Dali Chen; Zhongwei Wang
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

Review 6.  Membrane Carriers and Transporters in Kidney Physiology and Disease.

Authors:  Marek Drozdzik; Maria Drozdzik; Stefan Oswald
Journal:  Biomedicines       Date:  2021-04-14

Review 7.  From old uraemic toxins to new uraemic toxins: place of 'omics'.

Authors:  Ziad A Massy; Sophie Liabeuf
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

8.  The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients.

Authors:  Camille André; Touria Mernissi; Gabriel Choukroun; Youssef Bennis; Saïd Kamel; Sophie Liabeuf; Sandra Bodeau
Journal:  Toxins (Basel)       Date:  2021-12-25       Impact factor: 4.546

9.  Transporter-mediated interaction of indican and methotrexate in rats.

Authors:  Shiuan-Pey Lin; Chung-Ping Yu; Yu-Chi Hou; Ching-Ya Huang; Lu-Ching Ho; Shu-Ling Chan
Journal:  J Food Drug Anal       Date:  2017-12-14       Impact factor: 6.157

Review 10.  Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Authors:  Raymond E Lai; Christopher E Jay; Douglas H Sweet
Journal:  J Food Drug Anal       Date:  2018-03-24       Impact factor: 6.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.